CytomX Therapeutics, Inc. (CTMX) stock
CTMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.94−0.05 (-2.27%)
Close on Nov 17, 2026Market cap $422.73MP/E –Yield –
CytomX Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
CytomX Therapeutics's market cap was $386.80M on Nov 11, 2026, against $499.61M a year earlier. Over the last 5 years it ranged from $50.93M to $913.90M, with a median of $114.76M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $386.80M | -22.2% |
| 2025 | Dec 31, 2025 | $497.27M | +477.7% |
| 2024 | Dec 31, 2024 | $86.08M | -20.6% |
| 2023 | Dec 29, 2023 | $108.45M | +2.8% |
| 2022 | Dec 30, 2022 | $105.52M | -62.7% |
| 2021 | Dec 31, 2021 | $282.53M | -6.7% |
| 2020 | Dec 31, 2020 | $302.76M | -19.8% |
| 2019 | Dec 31, 2019 | $377.49M | -44.4% |
| 2018 | Dec 31, 2018 | $679.46M | -13.2% |
| 2017 | Dec 29, 2017 | $783.09M | +95.8% |
| 2016 | Dec 30, 2016 | $399.96M | +1650.7% |
| 2015 | Dec 31, 2015 | $22.85M | – |
See a number that looks wrong?